Hsbc Holdings PLC Has $29.46 Million Stock Holdings in The Cooper Companies, Inc. $COO

Hsbc Holdings PLC decreased its position in The Cooper Companies, Inc. (NASDAQ:COO) by 12.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 359,291 shares of the medical device company’s stock after selling 50,085 shares during the period. Hsbc Holdings PLC owned approximately 0.18% of Cooper Companies worth $29,459,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. New York Life Investment Management LLC lifted its stake in shares of Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares in the last quarter. Root Financial Partners LLC lifted its stake in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares in the last quarter. Allworth Financial LP lifted its stake in Cooper Companies by 14.1% during the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. boosted its holdings in Cooper Companies by 1.3% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after acquiring an additional 175 shares during the last quarter. Finally, Blue Trust Inc. boosted its holdings in Cooper Companies by 13.9% during the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after acquiring an additional 185 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Price Performance

COO opened at $68.83 on Thursday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The stock has a market capitalization of $13.42 billion, a PE ratio of 58.33, a price-to-earnings-growth ratio of 1.73 and a beta of 0.87. The stock’s 50 day moving average price is $64.11 and its 200-day moving average price is $73.74.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Wall Street Analyst Weigh In

COO has been the subject of a number of recent analyst reports. BNP Paribas Exane reduced their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, June 8th. Citigroup reissued a “neutral” rating and set a $69.00 target price (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Barclays lifted their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Finally, Wells Fargo & Company reissued a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $81.31.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.